FSPKF (Health Care Equipment) Stock Valuation & Fair Value Significantly overvalued
FSPKF (Health Care Equipment) trades at a blended P/E of 50.8, about 39% above its historical normal valuation, with a forward growth estimate of 16.5% and a PEG of 3.07. Analysts' one-year estimates have been hit 45% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
Valuation flags
- Overvalued by 39%
Verdict history
tickerseer's rating has been significantly overvalued since 2026-09-19.
Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is FSPKF overvalued?
At a blended P/E of 50.8 versus its historical normal P/E of 36.6, FSPKF trades about 39% above its typical valuation, with a PEG of 3.07 on 16.5% forward growth. tickerseer currently rates it significantly overvalued.
What is FSPKF's fair value and PEG?
FSPKF trades at a blended P/E of 50.8 against a historical normal P/E of 36.6, a PEG of 3.07, and a forward growth estimate of 16.5%.
Has tickerseer's rating of FSPKF changed?
tickerseer's rating has been significantly overvalued since 2026-09-19.
Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.